Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame
Primary	Change From Baseline in Mesangial Immunoglobulin A (IgA) Deposition by Immunofluorescence (IF)	Baseline, Week 36
Secondary	Change From Baseline in Mesangial IgA Deposition by IF	Baseline, Week 104
Secondary	Percent Change From Baseline in Proteinuria	Baseline up to Week 36
Secondary	Annualized Rate of Change (slope) in the Estimated Glomerular Filtration Rate (eGFR)	Baseline up to Week 104
Secondary	Change From Baseline in eGFR	Baseline up to Week 104
Secondary	Percentage of Participants Achieving Complete Response (CR)	Baseline up to Week 104
Secondary	Percentage of Participants who Progressed to Kidney Failure	Baseline up to Week 104
Secondary	Percentage of Participants With Treatment Emergent Adverse Event (TEAE) and Treatment Emergent Serious Adverse Event (TESAE)	Baseline up to Week 104
Secondary	Number of Participants with Clinically Significant Laboratory, Physical Examination, Vital Signs and Electrocardiograms (ECGs) Abnormalities	Baseline up to Week 104
Secondary	Felzartamab Serum Concentrations Over Time	Predose and at multiple timepoints postdose up to Week 36
Secondary	Number of Participants with Anti-Drug Antibodies (ADAs) Against Felzartamab	Baseline up to Week 104

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07889362/registered